Alibaba Health Information Technology Management
Management criteria checks 2/4
Alibaba Health Information Technology's CEO is Difan Shen, appointed in Nov 2023, has a tenure of less than a year. total yearly compensation is CN¥6.41M, comprised of 23% salary and 77% bonuses, including company stock and options. directly owns 0.007% of the company’s shares, worth HK$3.70M. The average tenure of the management team and the board of directors is 0.9 years and 1.6 years respectively.
Key information
Difan Shen
Chief executive officer
CN¥6.4m
Total compensation
CEO salary percentage | 23.0% |
CEO tenure | less than a year |
CEO ownership | 0.007% |
Management average tenure | less than a year |
Board average tenure | 1.6yrs |
Recent management updates
Recent updates
Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 36% Undervaluation?
Mar 12With A 25% Price Drop For Alibaba Health Information Technology Limited (HKG:241) You'll Still Get What You Pay For
Jan 17Is Now An Opportune Moment To Examine Alibaba Health Information Technology Limited (HKG:241)?
Jan 07Returns On Capital Are Showing Encouraging Signs At Alibaba Health Information Technology (HKG:241)
Dec 15Shareholders Should Be Pleased With Alibaba Health Information Technology Limited's (HKG:241) Price
Sep 28Alibaba Health Information Technology Limited's (HKG:241) Intrinsic Value Is Potentially 25% Below Its Share Price
Jul 02Is Alibaba Health Information Technology Limited (HKG:241) Potentially Undervalued?
Jun 11Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Jun 22Is There An Opportunity With Alibaba Health Information Technology Limited's (HKG:241) 49% Undervaluation?
Dec 01Alibaba Health Information Technology (HKG:241) Is Looking To Continue Growing Its Returns On Capital
Oct 15Estimating The Fair Value Of Alibaba Health Information Technology Limited (HKG:241)
Aug 12Alibaba Health Information Technology (HKG:241) Is Doing The Right Things To Multiply Its Share Price
Jun 25These Analysts Just Made A Huge Downgrade To Their Alibaba Health Information Technology Limited (HKG:241) EPS Forecasts
May 30Earnings Report: Alibaba Health Information Technology Limited Missed Revenue Estimates By 6.8%
May 27The Return Trends At Alibaba Health Information Technology (HKG:241) Look Promising
Mar 23Should You Be Adding Alibaba Health Information Technology (HKG:241) To Your Watchlist Today?
Mar 05How Much Are Alibaba Health Information Technology Limited (HKG:241) Insiders Taking Off The Table?
Feb 15Are Alibaba Health Information Technology's (HKG:241) Statutory Earnings A Good Reflection Of Its Earnings Potential?
Jan 31If You Had Bought Alibaba Health Information Technology (HKG:241) Stock Three Years Ago, You Could Pocket A 457% Gain Today
Dec 31Has Alibaba Health Information Technology Limited's (HKG:241) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Dec 16Will Alibaba Health Information Technology's (HKG:241) Growth In ROCE Persist?
Dec 01CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2023 | n/a | n/a | CN¥817m |
Jun 30 2023 | n/a | n/a | CN¥675m |
Mar 31 2023 | CN¥6m | CN¥1m | CN¥533m |
Dec 31 2022 | n/a | n/a | CN¥332m |
Sep 30 2022 | n/a | n/a | CN¥128m |
Jun 30 2022 | n/a | n/a | -CN¥69m |
Mar 31 2022 | CN¥6m | CN¥1m | -CN¥266m |
Dec 31 2021 | n/a | n/a | -CN¥216m |
Sep 30 2021 | n/a | n/a | -CN¥167m |
Jun 30 2021 | n/a | n/a | CN¥91m |
Mar 31 2021 | n/a | n/a | CN¥349m |
Dec 31 2020 | n/a | n/a | CN¥313m |
Sep 30 2020 | n/a | n/a | CN¥278m |
Jun 30 2020 | n/a | n/a | CN¥136m |
Mar 31 2020 | CN¥12m | CN¥2m | -CN¥7m |
Dec 31 2019 | n/a | n/a | -CN¥3m |
Sep 30 2019 | n/a | n/a | CN¥1m |
Jun 30 2019 | n/a | n/a | -CN¥40m |
Mar 31 2019 | CN¥7m | CN¥33k | -CN¥82m |
Compensation vs Market: Difan's total compensation ($USD886.47K) is about average for companies of similar size in the Hong Kong market ($USD927.61K).
Compensation vs Earnings: Difan's compensation has been consistent with company performance over the past year.
CEO
Difan Shen (45 yo)
less than a year
Tenure
CN¥6,406,000
Compensation
Mr. Difan Shen serves as Chief Executive Officer of Alibaba Health Information Technology Limited from November 28, 2023 and serves as Executive Director since October 13, 2021. He was Chief Operating Offi...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board | 4yrs | CN¥11.33m | 0.0081% CN¥ 4.1m | |
CEO & Executive Director | less than a year | CN¥6.41m | 0.0073% CN¥ 3.7m | |
CFO & Executive Director | 3.9yrs | CN¥3.24m | 0.0046% CN¥ 2.3m | |
Legal Counsel & Joint Company Secretary | 1.2yrs | no data | no data | |
Financial Controller | no data | no data | no data | |
Joint Company Secretary | less than a year | no data | no data |
0.9yrs
Average Tenure
45yo
Average Age
Experienced Management: 241's management team is not considered experienced ( 0.9 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Chairman of the Board | 4yrs | CN¥11.33m | 0.0081% CN¥ 4.1m | |
CEO & Executive Director | 2.4yrs | CN¥6.41m | 0.0073% CN¥ 3.7m | |
CFO & Executive Director | 3.4yrs | CN¥3.24m | 0.0046% CN¥ 2.3m | |
Independent Non-Executive Director | less than a year | no data | no data | |
Independent Non-Executive Director | 4.8yrs | CN¥330.00k | no data | |
Independent Non-Executive Director | less than a year | no data | no data | |
Non-Executive Director | less than a year | no data | no data | |
Non-Executive Director | less than a year | no data | no data |
1.6yrs
Average Tenure
47yo
Average Age
Experienced Board: 241's board of directors are not considered experienced ( 1.6 years average tenure), which suggests a new board.